e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Burden of comorbidities and NT-proBNP concentrations in stable COPD patients
L. Caram, R. Ferrari, A. Bertani, L. Coelho, S. Minamoto, I. Godoy (Botucatu, Brazil)
Source:
Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Session:
The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Session type:
Thematic Poster Session
Number:
3741
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Caram, R. Ferrari, A. Bertani, L. Coelho, S. Minamoto, I. Godoy (Botucatu, Brazil). Burden of comorbidities and NT-proBNP concentrations in stable COPD patients. Eur Respir J 2013; 42: Suppl. 57, 3741
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
The physiology of breathlessness
Related content which might interest you:
Impact of comorbidities in COPD prognosys scores
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
Impact of the nutritional status on pulmonary function in COPD patients
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013
Renal impairment a neglected comorbidity in patients with COPD
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
The severity of anxiety in COPD patients (pts)
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
COPD and BMI at primary level
Source: International Congress 2015 – Different data in COPD
Year: 2015
Comorbidity in patients with IHD - the prevalence of COPD
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Cardiovascular status of patients with a severe form of COPD
Source: International Congress 2015 – Diagnosing and management of COPD in primary care
Year: 2015
NT-proBNP in assessment of pulmonary hypertension in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Evaluation of arrhythmia frequency in patients with COPD
Source: International Congress 2015 – Different data in COPD
Year: 2015
The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Comorbidities in patients with COPD and their impact on COPD course
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014
The most frequent comorbidies in COPD and their inflence on the prognosis of the disease
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Circulating copeptin is associated with mortality irrespectively of exacerbation rate in stable COPD
Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities
Year: 2014
Role of comorbidities in stable COPD patients mortality
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
The distribution of phenotypes in a population of severe COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Cardiovascular comorbidities of COPD in never-smokers
Source: International Congress 2014 – Highlights in respiratory epidemiology
Year: 2014
Proteinase-inhibitor system state in patients with COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Alexithymia in COPD patients
Source: International Congress 2015 – Clinical problems in acute and chronic lung diseases
Year: 2015
Mortality and readmissions in patients with severe COPD. Validation of the CODEX index
Source: International Congress 2015 – Best abstracts in COPD management
Year: 2015
GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept